Researcher profile
Jim van Os
Affiliations
Organizations
Ankara Universityauthorship · TRCapital Region of Denmarkauthorship · DKCentro de Investigación Biomédica en Red de Salud Mentalauthorship · ESEuropean Graduate School of Neuroscienceauthorship · NLGGZ Rivierduinenauthorship · NLHologic (Germany)authorship · DEHospital General Universitario Gregorio Marañónauthorship · ESKing's College Londonauthorship · GBKing's College - North Carolinaauthorship · USKing's College Schoolauthorship · GBKings Health Partnersauthorship · GBMaastricht Universityauthorship · NLMaastricht University Medical Centreauthorship · NLMax Planck Institute of Psychiatryauthorship · DEPsychiatry Research Trustauthorship · GBTechnische Universität Dresdenauthorship · DEUniversidad de Londresauthorship · MXUniversity College Londonauthorship · GBUniversity Medical Centerauthorship · USUniversity Medical Center Groningenauthorship · NLUniversity Medical Center Utrechtauthorship · NLUniversity of Baselauthorship · CHUniversity of Cambridgeauthorship · GBUniversity of Groningenauthorship · NLUniversity of Londonauthorship · GBUtrecht Universityauthorship · NLYale Universityauthorship · US
Public evidence
18 connected articles
Clusters of social and substance use-related risks are associated with the duration of untreated psychosis.2026 · Europe PMCMethylomic signature of current cannabis use in two first-episode psychosis cohorts.2025 · Europe PMCThe impact of schizophrenia genetic load and heavy cannabis use on the risk of psychotic disorder in the EU-GEI case-control and UK Biobank studies.2024 · Europe PMCCannabis use and cognitive biases in people with first-episode psychosis and their siblings.2024 · Europe PMCThe Role of Social Deprivation and Cannabis Use in Explaining Variation in the Incidence of Psychotic Disorders: Findings From the EU-GEI Study.2024 · Europe PMCBidirectional relationships between cannabis use, anxiety and depressive symptoms in the mediation of the association with psychotic experience: further support for an affective pathway to psychosis2023 · PubMed Central Open AccessCannabis use as a potential mediator between childhood adversity and first-episode psychosis: results from the EU-GEI case-control study.2023 · Europe PMCFirst-Episode Psychosis Patients Who Deteriorated in the Premorbid Period Do Not Have Higher Polygenic Risk Scores Than Others: A Cluster Analysis of EU-GEI Data2023 · PubMed Central Open AccessThe association between reasons for first using cannabis, later pattern of use, and risk of first-episode psychosis: the EU-GEI case-control study.2023 · Europe PMCDaily use of high-potency cannabis is associated with more positive symptoms in first-episode psychosis patients: the EU-GEI case-control study.
Matched by exact identifiers only. Profile data: Corpus/OpenAlex.